Related Experiment Videos
Summary
Hemodialysis patients experienced increased plasma zinc levels post-treatment, primarily due to hemoconcentration and some zinc diffusion into the blood from the dialysate. This study examined zinc transfer during dialysis sessions.
Area of Science:
- Nephrology
- Clinical Chemistry
- Trace Element Metabolism
Background:
- Zinc is an essential trace element crucial for numerous physiological functions.
- Maintaining adequate zinc levels is important for patients with chronic kidney disease undergoing hemodialysis.
- Previous studies have suggested potential zinc loss or changes during hemodialysis.
Purpose of the Study:
- To investigate zinc transfer dynamics during hemodialysis.
- To determine the impact of hemodialysis on plasma zinc concentrations in patients.
- To differentiate between hemoconcentration and diffusion as causes for observed zinc level changes.
Main Methods:
- Plasma zinc concentrations and hematocrit were measured in 15 hemodialysis patients before and after a 5-hour dialysis session.
- Arterial blood and dialysate zinc levels were analyzed to assess diffusion across the dialyzer.
- Total serum protein was also monitored to evaluate hemoconcentration effects.
Main Results:
- Plasma zinc concentrations significantly increased from 74.0 ± 7.8 to 88.1 ± 9.7 µg/dL post-hemodialysis.
- This increase was largely attributed to hemoconcentration, evidenced by rising hematocrit and total serum protein.
- A significant increase in arterial plasma zinc (74.7 ± 8.1 to 80.2 ± 6.5 µg/dL) indicated diffusion into the blood, despite a non-significant decrease in dialysate zinc.
Conclusions:
- Hemodialysis can lead to an increase in plasma zinc concentrations in patients.
- Both hemoconcentration and diffusion across the dialyzer contribute to zinc level changes during dialysis.
- Further research may be needed to optimize zinc balance in hemodialysis patients.